Tegoprazan as First- and Second-Line Therapy for Eradication of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis.

J Dig Dis · 2025 · PMC12492059 · PMID 40826951

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Although eradication rates between TPZ‐ and PPI‐based regimens were not significantly different, TPZ‐based therapy showed a trend toward slightly higher adherence and adverse event rates (non‐significant).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.